Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia

scientific article published on 12 November 2011

Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AMJOTO.2011.10.011
P698PubMed publication ID22079094

P2093author name stringScott E Olitsky
P433issue3
P921main subjectnosebleedQ202013
hereditary hemorrhagic telangiectasiaQ776881
P304page(s)375-376
P577publication date2011-11-12
P1433published inAmerican Journal of OtolaryngologyQ13429339
P1476titleTopical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia
P478volume33

Reverse relations

cites work (P2860)
Q41103596A comparative study of propranolol versus silver nitrate cautery in the treatment of recurrent primary epistaxis in children
Q38365380Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
Q92710408Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial
Q99560535Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial
Q27317227Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management
Q34388065Optimal management of hereditary hemorrhagic telangiectasia
Q36657619The therapeutic efficacy of propranolol in children with recurrent primary epistaxis
Q42279034Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.
Q41959654Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants

Search more.